Is the plasma uridine level a marker of the overproduction of uric acid?

Metabolism: Clinical and Experimental

Volumn 46, Issue 7, 1997, Pages 801-804

  Yamamoto, Tetsuya ^a   Moriwaki, Yuji ^a   Takahashi, Sumio ^a   Tsutsumi, Zenta ^a   Yamakita, Jun Ichi ^a   Higashino, Kazuya ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

URIC ACID; URIDINE DERIVATIVE;

ADULT; ARTICLE; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; GOUT; HUMAN; HYPERURICEMIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PURINE METABOLISM; UREA CYCLE; URINARY EXCRETION;

EID: 0030764590     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90126-8     Document Type: Article

References (18)

1. Bishop C, Rand R, Tabott JH: Effect of benemid (p-g[di-n-propylsulfamyl]-benzoic acid) on uric acid metabolism in one normal and one gouty subject. J Clin Invest 30:889-895, 1951
2. Elion GB, Kovensky A, Hitchings GH, et al: Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. Biochem Pharmacol 15:863-880, 1966
3. Rundles RW, Wyngarrden JB, Hitchings GH, et al: Effects of xanthine oxidase inhibitor on thiopurine metabolism, hyperuricemia and gout. Trans Assoc Am Physicians 76:126-140, 1963
4. Jain AK, Ryan JR, McMahon FG, et al: Effect of single oral doses of benzbromarone on serum and urinary uric acid. Arthritis Rheum 17:149-157, 1974
5. Yamamoto T, Moriwaki Y, Takahashi S, et al: Effect of ethanol and fructose on plasma uridine and purine bases. Metabolism (in press)
6. Yamamoto T, Moriwaki Y, Takahashi S, et al: ATP consumption-induced increase in pyrimidine degradation (in Japanese). Nihom Naika Gakkai Zasshi 86:254, 1997 (suppl)
7. Wallance SL, Robinson H, Masi AT, et al: Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20:895-900, 1977
8. Yamamoto T, Moriwaki Y, Takahashi S, et al: Effect of amino acids on the excretion of purine bases and oxypurinol. Nephron 73:41-47, 1996
9. Van den Berghe G, Hers HG: Abnormal AMP deaminase in primary gout. Lancet 2:1090, 1980 (letter)
10. Dieppe PA: Investigation and management of gout in the young and the elderly. Ann Rheum Dis 91:263-266, 1989
11. Harkness RA: Hypoxanthine, xanthine and uridine in body fluids, indicators of ATP depletion. J Chromatogr 429:255-278, 1988
12. Swain JL, Sabina RL, McHale PA, et al: Prolonged myocardial nucleotide depletion after brief ischemia in the open-chest heart. Am J Physiol 242:H818-H826, 1982
13. Yamamoto T, Moriwaki Y, Takahashi S, et al: Effect of muscular exercise by bicycle ergometer on erythrocyte purine nucleotides. Horm Metab Res 26:504-508, 1994
14. Mineo I, Kono N, Hara N, et al: Myogenic hyperuricemia. A common pathophysiologic feature of glycogenesis types III, V and VII. N Engl J Med 317:75-80, 1987
15. Mineo I, Kono N, Shimizu T, et al: Excess purine degradation in exercising muscles of patients with glycogen storage disease types V and VII. J Clin Invest 76:556-560, 1985
16. Hara N, Kono N, Mineo I, et al: Enhanced release of ammonia and hypoxanthine from exercising muscle in patients with idiopathic hypoparathyroidism. Muscle Nerve 10:599-602, 1987
17. Garcia Puig J, Mateos FA: Clinical and biochemical aspects of uric acid overproduction. Pharm World Sci 16:40-54, 1994
18. Matsubara K, Matuzawa Y, Jiao S, et al: Relationship between hypertriglyceridemia and uric acid production in primary gout. Metabolism 38:698-701, 1984